US 11427822
Modified double-stranded RNA agents
granted A61PA61P43/00
Quick answer
US patent 11427822 (Modified double-stranded RNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P43/00